Literature DB >> 2193223

[Diagnosis of deep vein thrombosis by high resolution ultrasonography].

S Ogi1, K Tanaka, K Ito, H Hara, T Mori.   

Abstract

Using high resolution ultrasonography (US), diagnostic accuracy of thrombi in each venous segment of lower limbs and qualitative evaluation of thrombi in deep vein thrombosis (DVT) were investigated. The subjects were 106 lower limbs in 81 patients. The thrombi in common femoral vein (CFV), were diagnosed by compression technique and, were qualitatively analysed by echogenicity and consistency. Venography was performed in 18 limbs and histologic tests of thrombi were made in 6 limbs. The total accuracy of US was 100% for diagnosis of DVT, but was 83% for diagnosis of its extent. The total accuracy of US in each segment was greater than 90%, but the sensitivity of iliac veins was less than 90%. The thrombi in CFV were divided into 3 types and 8 sub-types. Type A was homogenous, type B was heterogenous, and type C was contracted echo. The types of us were consistent with results of histologic tests. We concluded that high resolution US is available for screening test for diagnosis of DVT and that qualitative evaluation of thrombi by US is a useful clinical test for selection of more adequate treatments.

Entities:  

Mesh:

Year:  1990        PMID: 2193223

Source DB:  PubMed          Journal:  Nihon Geka Gakkai Zasshi        ISSN: 0301-4894


  1 in total

1.  IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis.

Authors:  Christina Lückel; Felix Picard; Hartmann Raifer; Lucia Campos Carrascosa; Anna Guralnik; Yajuan Zhang; Matthias Klein; Stefan Bittner; Falk Steffen; Sonja Moos; Federico Marini; Renee Gloury; Florian C Kurschus; Ying-Yin Chao; Wilhelm Bertrams; Veronika Sexl; Bernd Schmeck; Lynn Bonetti; Melanie Grusdat; Michael Lohoff; Christina E Zielinski; Frauke Zipp; Axel Kallies; Dirk Brenner; Michael Berger; Tobias Bopp; Björn Tackenberg; Magdalena Huber
Journal:  Nat Commun       Date:  2019-12-16       Impact factor: 14.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.